rosiglitazone has been researched along with Chronic Lung Injury in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Cheng, Y; Li, X; Wang, R; Xu, Y; Yang, M | 1 |
Lee, C; Rehan, VK; Sakurai, R; Shen, H; Walther, FJ; Waring, AJ | 1 |
Gong, M; Husain, M; Husain, S; Ibe, B; Li, Y; Morales, E; Paek, D; Rehan, VK; Sakurai, R; Torday, JS | 1 |
Deprest, J; Jimenez, J; Nagatomo, T; Richter, J; Toelen, J; Vanoirbeek, J | 1 |
Biti, G; Bonomo, P; Bottoncetti, A; Cassani, S; Castiglione, F; Franzese, C; Gerini, C; Greto, D; Livi, L; Mangoni, M; Masoni, T; Meattini, I; Pallotta, S; Passeri, A; Pupi, A; Sottili, M; Vanzi, E | 1 |
Chen, C; Chen, XY; Ding, YM; Wang, B; Wang, WX; Xu, S; Yu, KH | 1 |
Corral, J; Ibe, B; Ihida-Stansbury, K; Krebs, M; Rehan, VK; Sakurai, R; Torday, JS | 1 |
Cai, Q; Xu, MY | 1 |
Patel, S; Rehan, VK; Santos, J; Torday, JS; Wang, Y | 1 |
9 other study(ies) available for rosiglitazone and Chronic Lung Injury
Article | Year |
---|---|
Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Topics: A549 Cells; Animals; Cell Death; Cell Line, Tumor; Coenzyme A Ligases; Disease Models, Animal; Epithelial Cells; Ferroptosis; Glutathione; Humans; Lipid Peroxidation; Lung; Lung Injury; Male; Mice; Mice, Inbred C57BL; Mitochondria; Phospholipid Hydroperoxide Glutathione Peroxidase; Reperfusion Injury; Rosiglitazone | 2020 |
A Combination of the Aerosolized PPAR-γ Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury in Rats.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Biomimetic Materials; Cell Differentiation; Female; Hyperoxia; Lung; Lung Injury; Male; Pioglitazone; PPAR gamma; Protein Precursors; Proteolipids; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Surface-Active Agents | 2018 |
Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Bronchoalveolar Lavage; Cell Differentiation; Female; Hyperoxia; Lung; Lung Injury; Male; Nebulizers and Vaporizers; Pioglitazone; PPAR gamma; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Surface-Active Agents; Thiazolidinediones | 2014 |
Transplacental Administration of Rosiglitazone Attenuates Hyperoxic Lung Injury in a Preterm Rabbit Model.
Topics: Animals; Female; Hyperoxia; Lung Injury; Maternal-Fetal Exchange; Pregnancy; Premature Birth; Rabbits; Rosiglitazone; Thiazolidinediones | 2016 |
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model.
Topics: Animals; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Lung Injury; Mice; PPAR gamma; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiation, Ionizing; Radiotherapy; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2015 |
Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.
Topics: Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Lung Injury; Male; Pancreatitis, Acute Necrotizing; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Taurocholic Acid; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2009 |
Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury.
Topics: Animals; Animals, Newborn; Cells, Cultured; Female; Fibroblasts; Humans; Hyperoxia; Lung Injury; PPAR gamma; Pregnancy; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2010 |
[Protective effect of rosiglitazone against hyperoxia-induced lung injury in neonatal rats].
Topics: Animals; Animals, Newborn; Bronchoalveolar Lavage Fluid; Female; Hyperoxia; Lung Injury; Male; Malondialdehyde; PPAR gamma; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2012 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo.
Topics: Actins; Anilides; Animals; Animals, Newborn; Cell Differentiation; Cells, Cultured; Female; Fibroblasts; Gene Expression; Hyperoxia; Lung; Lung Diseases; Lung Injury; Male; Membrane Proteins; Perilipin-2; PPAR gamma; Pregnancy; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein B; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2006 |